| Patent Number |
Title Of Patent |
Date Issued |
| D426130 |
Cutting tip wrench |
June 6, 2000 |
|
| D407488 |
Surgical handpiece |
March 30, 1999 |
|
| D397433 |
Surgical handpiece holder |
August 25, 1998 |
|
| D382399 |
Ophthalmic lens case |
August 19, 1997 |
|
| D381421 |
Surgical handpiece holder |
July 22, 1997 |
|
| D380550 |
Surgical console |
July 1, 1997 |
|
| D376207 |
Ophthalmic laser |
December 3, 1996 |
|
| D376204 |
Surgical handpiece |
December 3, 1996 |
|
| D375553 |
Surgical cassette adapter |
November 12, 1996 |
|
| D368434 |
Corneal topographer |
April 2, 1996 |
|
| D360068 |
Intraocular lens case |
July 11, 1995 |
|
| D354283 |
Surgical handpiece tip protector |
January 10, 1995 |
|
| D352106 |
Surgical console for ophthalmic surgery |
November 1, 1994 |
|
| D351227 |
Surgical handpiece shell |
October 4, 1994 |
|
| D351095 |
Cutting tip wrench |
October 4, 1994 |
|
| D349342 |
Intraocular lens folder |
August 2, 1994 |
|
| 6863073 |
Laminar cribosa puncture device, methods related to use of such a device and methods for treatin |
March 8, 2005 |
| Featured is a device for puncturing tissue of a body, such as the lamina cribosa and methods for treating a CVRO with such a puncturing device. The puncturing device includes a puncture member being generally configured and arranged to locally disrupt tissue proximal an area of the punct |
| 6630135 |
Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
October 7, 2003 |
| An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painful and potentially traumatic injections of antibiotics by utilizing sustained release compositions which allow the antibiotics con |
| 6509355 |
Treatment of disorders of the outer retina |
January 21, 2003 |
| This invention is directed to the use of glutamate antagonists to treat the disorders of outer retina. |
| 6486208 |
Sustained release, and comfortable opthalmic composition and method for ocular therapy |
November 26, 2002 |
| This invention relates to reduced stinging, sustained release ophthalmic formulations and the method of treatment comprising administering such formulations topically to the eye when in need thereof. |
| 6403590 |
Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
June 11, 2002 |
| Isoquinolinesulfonyl compounds are used in ophthalmic compositions to treat glaucoma or other ischemic-borne ocular disorders such as retinopathies or optic neuropathies. These compounds vasodilate ocular blood vessels, lower IOP and prevent or reduce the progression of visual field loss |
| 6399107 |
Use of inhibitors of gag synthesis for the treatment of corneal haze |
June 4, 2002 |
| This invention relates to the compositions and methods for the treatment of corneal haze. The compositions and methods are particularly directed to the use of GAG synthesis inhibitors in the treatment of corneal haze. |
| 6358897 |
Alkyl trypsin compositions and methods of use in contact lens cleaning and disinfecting systems |
March 19, 2002 |
| Improved stability, liquid enzyme compositions containing an alkylated trypsin and methods involving the combined use of these compositions with an aqueous composition are disclosed for the cleaning or simultaneous cleaning and disinfecting of contact lens. Methods for a daily use regime |
| 6353014 |
15-ketal postaglandins for the treatment of glaucoma or ocular hypertension |
March 5, 2002 |
| A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I: ##STR1## |
| 6353000 |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
March 5, 2002 |
| A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I: ##STR1## |
| 6331171 |
Tip for a liquefracture handpiece |
December 18, 2001 |
| A tip for a liquefraction surgical handpiece uses at least two tubes. One tube is used for aspiration and another, smaller tube is used to inject heated surgical fluid for liquefying a cataractous lens. The distal portion of the injection tube terminates just inside of the aspiration |
| 6316506 |
Conditioning solutions for contact lens care |
November 13, 2001 |
| Contact lens care compositions for the treatment of hard contact lenses arc disclosed. The compositions are useful for rinsing, cleaning, disinfecting and storing of hard contact lenses. The compositions contain an unique gelling system involving galactomannan polysaccharides and borates |
| 6303579 |
Use of calpain inhibitors to treat ocular neural pathology |
October 16, 2001 |
| The invention provides pharmaceutical compositions containing calpain inhibitors and methods of using these calpain inhibitors to prevent or ameliorate ocular neural tissue disease or damage. |
| 6274160 |
Methods of use of histamine H2 agonists in treating dry eye |
August 14, 2001 |
| A topical ophthalmic composition for the treatment of dry eye in humans, comprising one or more histamine H.sub.2 agonists, is disclosed. |
| 6271224 |
Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
August 7, 2001 |
| The present invention relates to the field of ophthalmology. In particular the invention relates to the field of ocular disorders including visual field loss and glaucoma using an isoquinolinesulfonyl compound, which lowers intraocular pressure (IOP) and produces dilation of ocular blood |
| 6242480 |
Ophthalmic viscoelastic compositions |
June 5, 2001 |
| Compounds having ant-inflammatory and anti-oxidant activity are disclosed. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms. Methods of treatment employing these properties of the compounds and corresponding pharmaceutical composition |
| 6242442 |
Brinzolamide and brimonidine for treating ocular conditions |
June 5, 2001 |
| Methods and compositions for treating ocular conditions which find their etiology in compromised ocular blood flow with brinzolamide and brimonidine are disclosed. |
| 6242441 |
Use of brinzolamide to prevent visual field loss |
June 5, 2001 |
| Methods for preventing or slowing visual field loss are disclosed. |
| 6241700 |
Surgical handpiece |
June 5, 2001 |
| A surgical handpiece having an integrated aspiration pump and vacuum and/or flow sensor. Suitable pumps included micromachined peristaltic pumps and ultrasonic pumps. |
| 6235781 |
Prostaglandin product |
May 22, 2001 |
| A pharmaceutical product comprising an aqueous prostaglandin formulation and a polypropylene container are disclosed. Aqueous prostaglandin formulations are more stable in polypropylene containers than polyethylene containers. |
| 6235779 |
Use of cis-.DELTA.4 analogs of prostaglandins as ocular hypotensives |
May 22, 2001 |
| Cis-.DELTA..sup.4 analogs of prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed. |
| 6232344 |
13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
May 15, 2001 |
| 13-Oxa analogs of certain prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed. |
| 6228323 |
Multi-purpose compositions containing an alkyl-trypsin and methods of use in contact lens cleani |
May 8, 2001 |
| Two-compartment bottle assemblies useful in preparing multi-purpose compositions containing an Al-trypsin and disinfectant, methods of preparing these compositions and methods involving the use of these compositions are disclosed for cleaning and disinfecting of contact lenses. |
| 6225332 |
Compositions containing histamine H2 agonists and methods of use in treating allergy and inflamm |
May 1, 2001 |
| Compositions containing histamine H.sub.2 agonists and methods of use for treating allergy and inflammation of the eye are disclosed. |
| 6225327 |
Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic- |
May 1, 2001 |
| Composition and methods for treating ocular allergic reactions are disclosed. In particular, the invention is directed to compounds which inhibit human conjunctival mast cell degranulation. |
| 6214596 |
Liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems |
April 10, 2001 |
| Stable liquid enzyme compositions containing an ophthalmically acceptable enzyme and methods involving the combined use of these compositions with an antimicrobial agent are disclosed for the simultaneous cleaning and disinfecting of contact lens. Methods for a daily use regimen are also |
| 6211238 |
Preservative system for topically administrable pharmaceutical compositions |
April 3, 2001 |
| Anionic surfactants are used in conjunction with an antifungal acid and a chelating agent to preserve topically administrable pharmaceutical compositions without the need for a conventional preservative such as benzalkonium chloride. |
| 6211226 |
11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
April 3, 2001 |
| 11-aza analogs of PGF.sub.2.alpha. and methods of their use in treating glaucoma and ocular hypertension are disclosed. |
| 6210438 |
Bicomposite intraocular lens and method for its preparation |
April 3, 2001 |
| Bicomposite intraocular lenses having an anterior surface material different from a posterior surface material are disclosed. The posterior surface material reduces the risk of posterior capsule opacification. |
| 6206848 |
Liquefracture handpiece |
March 27, 2001 |
| A surgical handpiece having two coaxial tubes or channels mounted within a body. The first tube is used for aspiration and is smaller in diameter than the second tube so as to great an annular passage between the first and second tube. The annular passage communicates with a pumping cham |
| 6200990 |
Neuroprotective agents having antioxidant and NMDA antagonist activity |
March 13, 2001 |
| The invention is directed to the use of novel compounds, compositions and methods for the prevention and treatment of neuronal tissue damage in mammals. The novel compounds comprise an antioxidant and a NMDA antagonist activity. |
| 6197812 |
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
March 6, 2001 |
| Substituted tetrahydrofuran analogs of prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed. |
| 6191126 |
Topical use of .kappa. opioid agonists to treat ocular pain |
February 20, 2001 |
| The present invention relates to the pharmaceutical treatment of pain. In particular, the present invention relates to the topical use of kappa opioid receptor agonists and partial agonists for the prevention or alleviation of pain in the eye. |
| 6187042 |
Intraocular lens coating compositions |
February 13, 2001 |
| Intraocular lens coating compositions for reducing the risk of posterior capsule opacification are disclosed. The coating materials, which differ from the substrate material, consist essentially of at least two aryl acrylic hydrophobic monomers of the formula ##STR1##wherein:X is H o |
| 6186868 |
Chilled temperature polishing method for soft acrylic articles |
February 13, 2001 |
| A method of polishing articles comprising soft acrylic materials is disclosed. The method includes a polishing step and a cleaning step. In the polishing step a receptacle is charged with polishing beads of various sizes, alumina, sodium hydroxide, water, a surfactant, and the articles t |
